Skip to main content
PRO MEDICUS LIMITED logo

PRO MEDICUS LIMITED — Investor Relations & Filings

Ticker · PME ISIN · AU000000PME8 LEI · 98450085A903D1BMFF27 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2025-03-16 Transaction in Own Shar…
Country AU Australia
Listing ASX PME

About PRO MEDICUS LIMITED

https://www.promed.com.au

Pro Medicus Limited provides advanced healthcare imaging software and enterprise-wide IT solutions. The company’s core offering is the Visage 7 platform, which employs server-side rendering technology to enable rapid, high-resolution streaming of medical images, including MRI, CT, and X-ray data. Its product suite encompasses diagnostic viewing, vendor-neutral archiving, and clinical workflow management. Designed for large-scale health systems and academic medical centers, the technology supports cloud-based deployments and integrates artificial intelligence to streamline diagnostic processes. The platform focuses on performance and scalability, allowing clinicians to access and interpret complex imaging datasets from multiple locations without the need for local data transfer.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - PME 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a company's on-market buy-back program, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement related to the company's repurchase of its own shares. The content matches the description of a 'Transaction in Own Shares' filing, which reports the company's buy-back activities. The document length is over 6,000 characters and contains substantive details about the buy-back, not just an announcement of a report or a certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2025-03-16 English
Notification of cessation of securities - PME 4 pages 14.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (cancellation) of a specific number of securities (ordinary fully paid shares) for PRO MEDICUS LIMITED. It includes specifics such as the number of securities ceased, the reason for cessation (buy-back), and the updated issued capital following the cessation. The document is a formal announcement notifying the market and regulatory bodies about changes in the company's issued securities. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement of a capital change event related to securities cessation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 3636 characters, which is consistent with an announcement rather than a full report.
2025-03-16 English
Update - Notification of buy-back - PME 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about the company's on-market buy-back program, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement specifically about the company's repurchase of its own shares. There are no financial statements or earnings data, nor is it a report or presentation. This fits the category of a Transaction in Own Shares (POS) filing, which covers share repurchase activities.
2025-03-13 English
Update - Notification of buy-back - PME 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a daily buy-back notification by Pro Medicus Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and compliance with ASX listing rules. The content is focused on reporting the company's share repurchase activity rather than financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document length is about 5,135 characters, which is sufficient to contain substantive details of the buy-back rather than just an announcement of a report publication. Therefore, the correct classification is POS (Transaction in Own Shares).
2025-03-12 English
Change of Director's Interest Notice - Anthony Glenning 2 pages 362.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references Listing Rule 3.19A.2, which pertains to disclosures of changes in directors' interests in securities. The content details a director's acquisition of shares, the nature of the interest, dates, and securities held before and after the change. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure of insider trading by a director, consistent with the definition of Director's Dealing filings. The document length is 3836 characters, which is typical for such notices. Therefore, the document is best classified as a Director's Dealing report.
2025-03-11 English
PME signs A$40M, 7-year contract with LucidHealth 2 pages 185.8KB
Capital/Financing Update Classification · 90% confidence The document is a company announcement about Pro Medicus Limited signing a A$40M, 7-year contract with LucidHealth. It details the contract terms, the product involved (Visage 7 Viewer), and the strategic significance of the deal. There are no financial statements, quarterly or annual results, or detailed financial performance data. The document is a press release announcing a significant contract win, which relates to the company's business operations and growth but does not fit into categories like Annual Report, Earnings Release, or Interim Report. It is not a regulatory filing, nor does it relate to board changes, voting results, or capital changes. The content is best classified as a Capital/Financing Update (CAP) because it announces a major contract that impacts the company's revenue and business outlook, which is typical for CAP filings.
2025-03-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.